Cesar Guerrero-Miranda MD FACC (@ivguerrerom) 's Twitter Profile
Cesar Guerrero-Miranda MD FACC

@ivguerrerom

Medical Director of #MCS | Advanced #HeartFailure, #Transplant and #LVAD #Cardiology. Father of Natalie & Daniel. ⚽️ fan. Tweets are my own. 🇵🇪

ID: 67221605

linkhttp://baylorhealth.com/transplant calendar_today20-08-2009 03:58:53

1,1K Tweet

1,1K Followers

1,1K Following

Marta Farrero (@martafarrero) 's Twitter Profile Photo

#ISHLTenEspañol at #ISHLT2024 opening plenary. So proud of the work done in the past 3 years and to see the community growing. Thanks to The ISHLT and ISHLT President and Andreas Zuckermann for their continued support and vision 😍

#ISHLTenEspañol at #ISHLT2024 opening plenary. So proud of the work done in the past 3 years and to see the community growing. Thanks to <a href="/ISHLT/">The ISHLT</a> and <a href="/ISHLTPres/">ISHLT President</a> and Andreas Zuckermann for their continued support and vision 😍
Lorena Montes (@loremontesvilla) 's Twitter Profile Photo

Today I did my presentation at #ISHLT 2024, at #ISHLTenespañol session and it was an incredible experience! Grateful for the opportunity to share insights in Latam problems and solutions #ISHLT2024

Today I did my presentation at #ISHLT 2024, at #ISHLTenespañol session and it was an incredible experience! Grateful for the opportunity to share insights in Latam problems and solutions #ISHLT2024
Cesar Guerrero-Miranda MD FACC (@ivguerrerom) 's Twitter Profile Photo

#hearttransplant patient with a high-risk profile for Non-HLA Abs 1. redoTXP 2. Preformed DSA 3. LVAD recipient 4. Early graft dysfunction with absent DSA 5. Lack of DSA post-AMR treatment #ISHLT2024

#hearttransplant patient with a high-risk profile for Non-HLA Abs
1. redoTXP
2. Preformed DSA
3. LVAD recipient
4. Early graft dysfunction with absent DSA
5. Lack of DSA post-AMR treatment
#ISHLT2024
Waqas Akhtar (@drwaqasakhtar) 's Twitter Profile Photo

Late breaking XVIVO preservation vs cold static storage for donor heart The ISHLT #ISHLT2024 Superiority RCT Filip Rega 🇪🇺 15 sites Europe N=229 Primary Outcome: ⭐️ Cardiac death/PGD/Rejection ACR2/graft failure in 30 days ⭐️ HR 0.56 (p 0.059) 61% risk reduction for PGD

Late breaking XVIVO preservation vs cold static storage for donor heart <a href="/ISHLT/">The ISHLT</a> #ISHLT2024 

Superiority RCT <a href="/RegaFilip/">Filip Rega</a> 

🇪🇺 15 sites Europe 

N=229

Primary Outcome:
⭐️ Cardiac death/PGD/Rejection ACR2/graft failure in 30 days
⭐️ HR 0.56 (p 0.059) 

61% risk reduction for PGD
Stavros George Drakos (@stavrosdrakos) 's Twitter Profile Photo

1/. Ten projects from “VAD WEAN” Cardiac Recovery Registry (50 sites worldwide, >600 HF pts) being presented @ #ISHLT2024. Exciting results: ⁃Long-term “Survival Free of VAD/Tx post-VAD weaning” equivalent to propensity matched “ISHLT Registry post-Transplant Survival”

1/. Ten projects from “VAD WEAN” Cardiac Recovery Registry (50 sites worldwide, &gt;600 HF pts) being presented @ #ISHLT2024. Exciting results:
⁃Long-term “Survival Free of VAD/Tx post-VAD weaning” equivalent to propensity matched “ISHLT Registry post-Transplant Survival”
Cesar Guerrero-Miranda MD FACC (@ivguerrerom) 's Twitter Profile Photo

#ISHLT2024 was unforgettable, shared ideas on #MCS & #LVAD with colleagues worldwide. Humbled to talk about the evidence #LVAD to achieve #myocardialrecovery and #LVADWean & share Baylor Scott & White Health system protocol, hope to inspire unified protocols & ideas to improve #recovery outcomes

#ISHLT2024 was unforgettable, shared ideas on #MCS &amp; #LVAD with colleagues worldwide. Humbled to talk about the evidence #LVAD to achieve #myocardialrecovery and #LVADWean &amp; share <a href="/bswhealth/">Baylor Scott & White Health</a> system protocol, hope to inspire unified protocols &amp; ideas to improve #recovery outcomes
Cesar Guerrero-Miranda MD FACC (@ivguerrerom) 's Twitter Profile Photo

Learning about pre and post-transplant reproductive health, contraception options, and medication interactions with immunosuppressants from transplant experts. #ATC2024 Aasim Afzal MD FHFSA

Learning about pre and post-transplant reproductive health, contraception options, and medication interactions with immunosuppressants from transplant experts. #ATC2024 <a href="/afzal_aasim/">Aasim Afzal MD FHFSA</a>
The ISHLT (@ishlt) 's Twitter Profile Photo

📢 A NEW #ISHLTConsensusStatement on Strategies to Prevent and Manage #Hemocompatibility Related Adverse Events in Patients with Durable #VADs is now available online at bit.ly/hemoconsensus. Check out the top takeaways from this document below. ⏬🫀💡 #HF #TxPharm #LVAD

📢 A NEW #ISHLTConsensusStatement on Strategies to Prevent and Manage #Hemocompatibility Related Adverse Events in Patients with Durable #VADs is now available online at bit.ly/hemoconsensus.

Check out the top takeaways from this document below. ⏬🫀💡  #HF #TxPharm #LVAD
JHLT (@thejhlt) 's Twitter Profile Photo

In the US, LVAD BTT is expected to remain a minority due to the features of the txp allocation system. Meanwhile, in Europe, donor scarcity & the increasing expertise in advanced heart failure are anticipated to ⏫ LVAD utilization. Andrea Fernandez Valledor, MD 🔗: jhltonline.org/article/S1053-…

In the US, LVAD BTT is expected to remain a minority due to the features of the txp allocation system. Meanwhile, in Europe, donor scarcity &amp; the increasing expertise in advanced heart failure are anticipated to ⏫ LVAD utilization. <a href="/andreavalledor1/">Andrea Fernandez Valledor, MD</a> 

🔗: jhltonline.org/article/S1053-…